News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
147 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17556)
Month
January (2987)
February (3289)
March (3625)
April (3424)
May (3732)
June (3552)
July (2687)
August (3042)
September (3454)
October (3101)
November (3075)
December (2362)
Day
1 (143)
2 (108)
5 (184)
6 (175)
7 (136)
8 (162)
9 (93)
11 (4)
12 (124)
13 (140)
14 (133)
15 (134)
16 (90)
19 (147)
20 (138)
21 (115)
22 (91)
27 (107)
28 (37)
29 (54)
30 (47)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
11
12
13
14
15
16
19
20
21
22
27
28
29
30
Profounda Receives FDA Orphan-Drug Designation For The Treatment Of Primary Amebic Meningoencephalitis (PAM) With Miltefosine
December 19, 2016
·
3 min read
FDA
NovoCure’s Optune (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma
December 19, 2016
·
7 min read
Policy
ProMetic Life Sci Initiates Rolling Submission Of Its Biologics License Application (“BLA”) For Plasminogen With U.S. FDA
December 19, 2016
·
5 min read
Business
Shionogi And Purdue Pharma L.P. Establish Alliance For Joint U.S. Commercialization Of Naldemedine
December 19, 2016
·
5 min read
FDA
Merck & Co. Release: KEYTRUDA (Pembrolizumab) Approved As First Anti-PD-1 Therapy In Japan For First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express High Levels Of PD-L1
December 19, 2016
·
13 min read
Business
AmerisourceBergen Names Keri Mattox As Vice President, Corporate And Investor Relations
December 19, 2016
·
7 min read
Business
Ferring Pharma And IMAB Sign Licensing Agreement Granting IMAB Exclusive Rights In Asia To Olamkicept For The Treatment Of Autoimmune Disease
December 19, 2016
·
2 min read
FDA
Ironwood Announces Approval Of LINZESS (Linaclotide) In Japan For The Treatment Of Adults With IBS-C
December 19, 2016
·
9 min read
ProMetic Life Sci Comments On Unusual Trading Activity
December 19, 2016
·
2 min read
Business
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt As Chief Operating Officer
December 19, 2016
·
5 min read
Previous
8 of 15
Next
